Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 20/20 | 0.38 |
| ▸ | CDK6 | Q00534 | 11/20 | 0.35 |
| ▸ | CCND3 | P30281 | 9/20 | 0.35 |
| ▸ | CCND1 | P24385 | 9/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 7/20 | 0.35 |
| ▸ | CDK2 | P24941 | 6/20 | 0.35 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 7/20 | 0.35 |
| ▸ | CCNB1 | P14635 | 6/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.34 |
| ▸ | CDK7 | P50613 | 4/20 | 0.34 |
| ▸ | CCNH | P51946 | 4/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.34 |
| ▸ | CDK9 | P50750 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650634 | 0.94 | EGFR (0.38) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650590 | 0.93 | CDK4 (0.35) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650776 | 0.84 | CDK4 (0.36) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650513 | 0.83 | CDK4 (0.36) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650429 | 0.82 | CCND1 (0.40) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650858 | 0.81 | CDK4 (0.41) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650546 | 0.81 | CDK4 (0.42) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650560 | 0.81 | CCND1 (0.36) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650859 | 0.79 | CDK4 (0.51) | CDK4CDK6CCND3CCND1CCNA2 | |
| SCHEMBL22650574 | 0.78 | CDK4 (0.43) | CDK4CDK6CCND3CCND1CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020224568-A1 | CDK INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2020-11-12 | — | — | WO | disclosed |